精神分裂症死亡率的系统评价:不同死亡率差距是否随时间推移而恶化?
A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?
作者信息
Saha Sukanta, Chant David, McGrath John
机构信息
Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol Q4076, Australia.
出版信息
Arch Gen Psychiatry. 2007 Oct;64(10):1123-31. doi: 10.1001/archpsyc.64.10.1123.
CONTEXT
Despite improvements in mental health services in recent decades, it is unclear whether the risk of mortality in schizophrenia has changed over time.
OBJECTIVE
To explore the distribution of standardized mortality ratios (SMRs) for people with schizophrenia.
DATA SOURCES
Broad search terms were used in MEDLINE, PsychINFO, Web of Science, and Google Scholar to identify all studies that investigated mortality in schizophrenia, published between January 1, 1980, and January 31, 2006. References were also identified from review articles, reference lists, and communication with authors.
STUDY SELECTION
Population-based studies that reported primary data on deaths in people with schizophrenia.
DATA EXTRACTION
Operationalized criteria were used to extract key study features and mortality data.
DATA SYNTHESIS
We examined the distribution of SMRs and pooled selected estimates using random-effects meta-analysis. We identified 37 articles drawn from 25 different nations. The median SMR for all persons for all-cause mortality was 2.58 (10%-90% quantile, 1.18-5.76), with a corresponding random-effects pooled SMR of 2.50 (95% confidence interval, 2.18-2.43). No sex difference was detected. Suicide was associated with the highest SMR (12.86); however, most of the major causes-of-death categories were found to be elevated in people with schizophrenia. The SMRs for all-cause mortality have increased during recent decades (P = .03).
CONCLUSIONS
With respect to mortality, a substantial gap exists between the health of people with schizophrenia and the general community. This differential mortality gap has worsened in recent decades. In light of the potential for second-generation antipsychotic medications to further adversely influence mortality rates in the decades to come, optimizing the general health of people with schizophrenia warrants urgent attention.
背景
尽管近几十年来心理健康服务有所改善,但尚不清楚精神分裂症患者的死亡率风险是否随时间而变化。
目的
探讨精神分裂症患者标准化死亡率(SMR)的分布情况。
数据来源
在MEDLINE、PsychINFO、科学网和谷歌学术中使用广泛的检索词,以识别1980年1月1日至2006年1月31日期间发表的所有调查精神分裂症死亡率的研究。还从综述文章、参考文献列表以及与作者的交流中识别参考文献。
研究选择
报告精神分裂症患者死亡原始数据的基于人群的研究。
数据提取
使用可操作的标准提取关键研究特征和死亡率数据。
数据综合
我们检查了SMR的分布,并使用随机效应荟萃分析汇总选定的估计值。我们从25个不同国家的文献中识别出37篇文章。所有原因导致的全人群死亡率的SMR中位数为2.58(第10百分位数-第90百分位数,1.18-5.76),相应的随机效应汇总SMR为2.50(95%置信区间,2.18-2.43)。未检测到性别差异。自杀的SMR最高(12.86);然而,发现精神分裂症患者的大多数主要死亡原因类别都有所升高。近几十年来,全因死亡率的SMR有所上升(P = 0.03)。
结论
在死亡率方面,精神分裂症患者的健康状况与普通人群之间存在巨大差距。近几十年来,这种死亡率差异差距有所恶化。鉴于第二代抗精神病药物在未来几十年可能进一步对死亡率产生不利影响,优化精神分裂症患者的总体健康状况值得紧急关注。